# Cresco Labs Inc.: Form 40-F for the period ended Dec 31, 2021

- Company: [Cresco Labs Inc.](/companies/crlbf.md) (CIK 1832928)
- Form: 40-F
- Filed: 2022-04-05
- Accepted by EDGAR: Apr 5, 2022, 17:19 ET
- Period: 2021-12-31
- Accession: 0001193125-22-096315
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1832928/000119312522096315/d423706d40f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1832928/000119312522096315/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $821.7m | ifrs-full:Revenue |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $415.3m | ifrs-full:CostOfSales |
| Gross profit | 12 months, 2021-01-01 to 2021-12-31 | $406.3m | ifrs-full:GrossProfit |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | −$217.4m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $40.1m | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | −$319.6m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | $14.5m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $93.9m | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2021-12-31 | $223.5m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2021-12-31 | $421.8m | ifrs-full:CurrentAssets |
| Total assets | at 2021-12-31 | $1.78bn | ifrs-full:Assets |
| Current liabilities | at 2021-12-31 | $288.4m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2021-12-31 | $982.7m | ifrs-full:Liabilities |
| Shareholders' equity | at 2021-12-31 | $755.6m | ifrs-full:EquityAttributableToOwnersOfParent |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1832928/000119312522096315/d423706d40f.htm

Filed Apr 5, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-096315. Last ingested by Listed: Nov 6, 2026, 12:03 ET. No prices; not investment advice.
